🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Delighted that our study on risk factors for premature coronary #heartdisease in the Women's Health Study made it in the top 10 JAMA Cardiology articles for 2021 BWH Preventive Medicine Brigham and Women’s Research @nih_nhlbi ow.ly/ynRP50DkVc1

ICYMI: “It appears that modifying contractility dynamics without a significant chronotropic effect with mavacamten is sufficient to relieve [left ventricular outflow tract] obstruction,” American College of Cardiology Sheila Hegde Brigham and Women’s Research #CardioTwitter healio.com/news/cardiolog…

Looking forward to launching this NEJM Evidence Review Series where we wrestle with the evidence for exercise in medicine. #WhyExercise. (thread)

Spectral Doppler shape so helpful in differentiating left-sided lesions. MR vs AS vs LVOT vs Mid-ventricular obstruction. Lots of learning at JOINT American Society of Echocardiography American College of Cardiology 💥”Thick Hearts” 💥 Session #ACC22

Looking forward to the results. Congrats to scottdavidsolomon and the entire team! A special thanks to all the patients who participated.

Inspiring #BrighamCVGrandRounds today by scottdavidsolomon Describing remarkable and hopeful journey of progress in #HFpEF drug development Closing with this last chapter from #DELIVER delivertrial.org ICYMI Recording soon to be available: bwhedtech.media.partners.org/programs/cvgr/

The #IJCVI editors' aim is stellar! Let's meet them & know their aim in this video🌠 Sheila Hegde Thomas H Schindler BorekFoldyna Raymond Kwong Alexander Rosendael Marco Guglielmo MD, FEACVI, FSCCT Alberto Cipriani Dominik C. Benz Lorenz Räber, MD PhD Anna Giulia Pavon Isaac Shiri Lord @shehabanwer Christoph Gräni Julia Grapsa MD, PhD @hragy #CardioTwitter

Masterclass Brigham and Women's Hospital Grand Rounds by Tor Biering-Sørensen, MD, MSc, MPH, PhD Remarkable breadth of high quality randomized evidence being generated by efficiently leveraging the Danish nationwide registries The future of clinical trials is here!

Enormous congrats to Brittany Weber for winning the #SCCT2024 YIA competition "Prevalence and Prognostic Implications of Incidentally Detected Coronary Artery Calcium Using Artificial Intelligence Analysis Among Individuals with Immune Mediated inflammatory Diseases" #CardioRheum 🏅

Not to be missed. Two greats Marianna Fontana & Sarah Cuddy presenting and discussing a sure-to-be practice changing trial of an entirely new way to modify outcomes in ATTR-CM First Hotline to kick off #ESCCongress

#Aficamten 1/6 presentation. Follow along Here are the results of the #SEQUOIA #HCM #whyCMR substudy (aficamten vs placebo on oHCM) which is also simultaneously published in JACC Journals #CardioTwitter

#aficamten 2/6 presentation Here is the KCCQ and SAQ-SS analysis from the SEQUOIA-HCM trial presented by John Spertus #ESCCongress With simultaneous publication in JACC Journals jacc.org/doi/10.1016/j.… #CardioTwitter

#Aficamten 3/6 presentation Here are the data on the detailed #echofirst analysis of #SEQUOIA #HCM trial #ESCCongress presented by Sheila Hegde Simultaneously published in JACC Journals jacc.org/doi/10.1016/j.… #CardioTwitter

Aficamten therapy improves #echofirst measures of cardiac structure and function in patients with symptomatic obstructive #HCM in the SEQUOIA-HCM study bit.ly/3APYefQ #cvImaging #cvHCM #ESCCongress #JACC Sheila Hegde scottdavidsolomon

#Aficamten 4/6 presentation This is a study from #FOREST-HCM trial where we withdrew beta blockers/calcium channel blockers/disopyramide from patients with obstructive #HCM on stable dose of aficamten. What did we find? #ESCCongress #CardioTwitter

#Aficamten 5/6 presentation In this innovative NT-proBNP/hs-troponin analysis (#SEQUOIA-HCM, afi vs placebo in oHCM) Caroline Coats and @JJheart_doc show novel data on these biomarkers in obstructive #HCM Simultaneous pub in European Society of Cardiology Journals #ESCCongress #CardioTwitter

What a pleasure to see my mentors presenting the results of #FINEARTS at #ESC2024. Finerenone reduced the primary combined endpoint of HF hosp. and CV death in patients with HFmrEF and HFpEF

At Scripps Health cardiomyopathy / amyloid conference. Sarah Cuddy excellent talk when to suspect cardiac amyloidosis! 🍩 classic findings are not so classic. Don’t rely on “speckled appearance” on #Echofirst 🍩 asymmetric LVH not that uncommon in amyloid population 🍩 screen

1/n We are excited to announce EchoPrime – the first echocardiography AI model capable of evaluating a full transthoracic echocardiogram study, identify the most relevant videos, and produce a comprehensive interpretation! Great work lead by Milos Vukadinovic, EchoPrime is the largest